Approaches to preventing prandial hyperglycemic excursions

Current Opinion in Endocrinology and Diabetes

Volumn 6, Issue SUPPL. 1, 1999, Pages

  Kelley, David ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN;

CONFERENCE PAPER; GLUCOGENESIS; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN TREATMENT; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; TREATMENT PLANNING;

EID: 0033428825     PISSN: 10683097     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (19)

1. Lillioja S, Mott D, Howard B, et al.: Impaired glucose tolerance as a disorder of insulin action. N Engl J Med 1988, 318:1217-1225.
2. Warram J, Martin B, Krolewski A, et al: Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents. Ann Intern Med 1990, 113:909-915.
3. Mitrakou A, Kelley D, Mokan M, et al.: Role of reduced suppression of glucose production and diminished early insulin release in impaired glucose tolerance. N Engl J Med 1992, 326:22-29.
4. Dinneen SF: The postprandial state: mechanisms of glucose intolerance. Diabetic Med 1997, 14(suppl 3):S19-S24.
5. Firth R, Bell P, Marsh M, et al.: Effects of tolazamide and exogenous insulin on pattern of postprandial carbohydrate metabolism in patients with non-insulin-dependent diabetes mellitus. Results of randomized crossover trial. Diabetes 1987, 36:1130-1138.
6. Ferrannini E, Simonson DC, Katz LD, et al.: The disposal of an oral glucose load in patients with non-insulin-dependent diabetes. Metabolism 1988, 37:79-85.
7. Kelley D, Mitrakou A, Marsh H, et al.: Skeletal muscle glycolysis, oxidation, and storage of an oral glucose load. J Clin Invest 1988, 81:1563-1571.
8. Luzi L, DeFronzo RA: Effect of loss of first-phase insulin secretion on hepatic glucose production and tissue glucose disposal in humans. Am J Physiol 1989, 257:E241-E246.
9. Kelley D, Mokan M, Veneman T: Impaired postprandial glucose utilization in non-insulin-dependent diabetes mellitus. Metabolism 1994, 43:1549-1557.
10. Bruce DG, Chisholm DJ, Storlien LH, et al.: Physiological importance of deficiency in early prandial insulin secretion in non-insulin-dependent diabetes. Diabetes 1988, 37:736-744.
11. Jeng CY, Hollenbeck CB, Wu MS, et al: How does glibenclamide lower plasma glucose concentration in patients with type 2 diabetes? Diabetic Med 1989, 6:303-308.
12. Andreani D, Lefèvre P, editors. Metformin: mechanisms of action and clinical use. Diabetes Metab Rev 1995, 11 (suppl 1):S1-108.
13. Riccio A, Del Prato S, Vigili de Kreutzenberg S, et al.: Glucose and lipid metabolism in non-insulin-dependent diabetes. Effect of metformin. Diabetes Metab 1991, 17:180-184.
14. Cusi K, Consoli A, DeFronzo RA: Metabolic effects of metformin on glucose and lactate metabolism in non-insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1996, 81:4059-4067.
15. Reaven GM: Effect of metformin on various aspects of glucose, insulin and lipid metabolism in patients with non-insulin-dependent diabetes mellitus with varying degrees of hyperglycemia. Diabetes Metab Rev 1995, 11(suppl 1):S97-S108.
16. Suter SL, Nolan JJ, Wallace P, et al.: Metabolic effects of new oral hypoglycemic agent CS-045 in NIDDM subjects. Diabetes Care 1992, 15:193-203.
17. Chiasson JL, Josse RG, Hunt JA, et al.: The efficacy and safety of acarbose in the treatment of patients with non-insulin-dependent diabetes mellitus: a multicenter controlled clinical trial. Ann Intern Med 1994, 121:928-935.
18. Coniff RF, Shapiro JA, Seaton TB: Long-term efficacy and safety of acarbose in the treatment of obese subjects with non-insulin-dependent diabetes mellitus. Arch Intern Med 1994, 154:2442-2448.
19. Coniff RF, Shapiro JA, Seaton TB: Multicenter, placebo-controlled trial comparing acarbose (BAY g 5421) with placebo, tolbutamide and tolbutamide-plus-acarbose in non-insulin-dependent diabetes mellitus. Am J Med 1995, 98:443-451.